Advances in metabolic imaging for surgical oncology

Andrei Iagaru; Andrew Quon

doi:10.1016/j.soc.2007.03.007

Advances in metabolic imaging for surgical oncology

Surg Oncol Clin N Am. 2007 Apr;16(2):273-92. doi: 10.1016/j.soc.2007.03.007.

Authors

Andrei Iagaru¹, Andrew Quon

Affiliation

¹ Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Drive, Room H-0101, Stanford, CA 94305, USA.

PMID: 17560512
DOI: 10.1016/j.soc.2007.03.007

Abstract

This review focuses on several aspects of molecular imaging. First, current positron emission tomography (PET)/CT scanner technology and several novel imaging techniques that are being developed are briefly discussed. Next, current clinical indications for (18)F FDG PET and PET/CT that are relevant to the surgical oncologist are discussed. Finally, advances in molecular imaging that may herald the next generation of PET radiotracers beyond (18)F FDG are reviewed.

Publication types

Review

MeSH terms

Diagnostic Imaging*
Fluorodeoxyglucose F18
Humans
Medical Oncology / methods
Medical Oncology / trends*
Neoplasms / diagnostic imaging*
Positron-Emission Tomography
Radiopharmaceuticals
Tomography, X-Ray Computed

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18